Johnson & Johnson HIV vaccine trial fails mid-stage study
(NEW YORK) -- In yet another setback in the decadeslong scientific quest for an HIV vaccine, a Johnson & Johnson HIV vaccine candidate failed to reduce the risk of infection in a clinical trial among women in southern Africa. The would-be vaccine uses the same... Read More.